Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Yamamoto M, Du Q, Song J, Wang H, Watanabe A, Tanaka Y, Kawaguchi Y, Inoue JI, Matsuda Z.

J Biol Chem. 2019 Apr 5;294(14):5677-5687. doi: 10.1074/jbc.RA118.004579. Epub 2019 Feb 8.

PMID:
30737278
2.

Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.

Liu D, Wang H, Yamamoto M, Song J, Zhang R, Du Q, Kawaguchi Y, Inoue JI, Matsuda Z.

Retrovirology. 2018 Apr 2;15(1):27. doi: 10.1186/s12977-018-0410-9.

3.

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.

Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov.

4.

Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins.

Saw WT, Matsuda Z, Eisenberg RJ, Cohen GH, Atanasiu D.

Methods. 2015 Nov 15;90:68-75. doi: 10.1016/j.ymeth.2015.05.021. Epub 2015 May 26. Review.

5.

Dual Split Protein (DSP) Assay to Monitor Cell-Cell Membrane Fusion.

Nakane S, Matsuda Z.

Methods Mol Biol. 2015;1313:229-36. doi: 10.1007/978-1-4939-2703-6_17.

PMID:
25947669
6.

Recent advance in the structural analysis of HIV-1 envelope protein.

Matsuda Z.

Sci China Life Sci. 2015 May;58(5):420-4. doi: 10.1007/s11427-015-4852-1. Epub 2015 Apr 29. Review.

PMID:
25921945
7.

The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.

Nakane S, Iwamoto A, Matsuda Z.

J Biol Chem. 2015 Jun 12;290(24):15279-91. doi: 10.1074/jbc.M114.628610. Epub 2015 Apr 24.

8.

Co-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain.

Wang H, Li X, Nakane S, Liu S, Ishikawa H, Iwamoto A, Matsuda Z.

PLoS One. 2014 May 7;9(5):e96790. doi: 10.1371/journal.pone.0096790. eCollection 2014.

9.

Development of a rapid cell-fusion-based phenotypic HIV-1 tropism assay.

Teeranaipong P, Hosoya N, Kawana-Tachikawa A, Fujii T, Koibuchi T, Nakamura H, Koga M, Kondo N, Gao GF, Hoshino H, Matsuda Z, Iwamoto A.

J Int AIDS Soc. 2013 Sep 18;16:18723. doi: 10.7448/IAS.16.1.18723.

10.

Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.

Atanasiu D, Saw WT, Gallagher JR, Hannah BP, Matsuda Z, Whitbeck JC, Cohen GH, Eisenberg RJ.

J Virol. 2013 Nov;87(21):11332-45. doi: 10.1128/JVI.01700-13. Epub 2013 Aug 14.

11.
12.

Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP.

Ishikawa H, Meng F, Kondo N, Iwamoto A, Matsuda Z.

Protein Eng Des Sel. 2012 Dec;25(12):813-20. doi: 10.1093/protein/gzs051. Epub 2012 Aug 30.

PMID:
22942393
13.

Dynamic appearance of antigenic epitopes effective for viral neutralization during membrane fusion initiated by interactions between HIV-1 envelope proteins and CD4/CXCR4.

Toda T, Kuwahara K, Kondo N, Matsuda Z, Maeda Y, Maeda K, Sakaguchi N.

Immunobiology. 2012 Sep;217(9):864-72. doi: 10.1016/j.imbio.2011.12.007. Epub 2011 Dec 23.

PMID:
22226668
14.

Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion.

Long Y, Meng F, Kondo N, Iwamoto A, Matsuda Z.

Protein Cell. 2011 May;2(5):369-76. doi: 10.1007/s13238-011-1051-0. Epub 2011 Jun 12.

15.

Monitoring viral-mediated membrane fusion using fluorescent reporter methods.

Kondo N, Miyauchi K, Matsuda Z.

Curr Protoc Cell Biol. 2011 Mar;Chapter 26:Unit 26.9. doi: 10.1002/0471143030.cb2609s50.

PMID:
21400700
16.

Interferon-gamma negatively regulates Th17-mediated immunopathology during mouse hepatitis virus infection.

Yang W, Ding X, Deng J, Lu Y, Matsuda Z, Thiel A, Chen J, Deng H, Qin Z.

J Mol Med (Berl). 2011 Apr;89(4):399-409. doi: 10.1007/s00109-010-0711-5. Epub 2010 Dec 30.

PMID:
21191565
17.

Membrane topology analysis of HIV-1 envelope glycoprotein gp41.

Liu S, Kondo N, Long Y, Xiao D, Iwamoto A, Matsuda Z.

Retrovirology. 2010 Nov 30;7:100. doi: 10.1186/1742-4690-7-100.

18.

The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.

Miyauchi K, Curran AR, Long Y, Kondo N, Iwamoto A, Engelman DM, Matsuda Z.

Retrovirology. 2010 Nov 13;7:95. doi: 10.1186/1742-4690-7-95.

19.

Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain.

Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z.

J Biol Chem. 2010 May 7;285(19):14681-8. doi: 10.1074/jbc.M109.067090. Epub 2010 Mar 2.

20.

Monitoring of HIV-1 envelope-mediated membrane fusion using modified split green fluorescent proteins.

Wang J, Kondo N, Long Y, Iwamoto A, Matsuda Z.

J Virol Methods. 2009 Nov;161(2):216-22. doi: 10.1016/j.jviromet.2009.06.017. Epub 2009 Jun 25.

PMID:
19559731
21.

Thermus thermophilus-derived protein tags that aid in preparation of insoluble viral proteins.

Kondo N, Ebihara A, Ru H, Kuramitsu S, Iwamoto A, Rao Z, Matsuda Z.

Anal Biochem. 2009 Feb 15;385(2):278-85. doi: 10.1016/j.ab.2008.10.050. Epub 2008 Nov 19.

PMID:
19084492
22.

In vitro translation to study HIV protease activity.

Matsuda Z, Iga M, Miyauchi K, Komano J, Morishita K, Okayama A, Tsubouchi H.

Methods Mol Biol. 2007;375:135-49. Review.

PMID:
17634600
23.

Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.

Shimizu S, Urano E, Futahashi Y, Miyauchi K, Isogai M, Matsuda Z, Nohtomi K, Onogi T, Takebe Y, Yamamoto N, Komano J.

AIDS. 2007 Mar 12;21(5):575-82.

PMID:
17314519
24.

Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4.

Futahashi Y, Komano J, Urano E, Aoki T, Hamatake M, Miyauchi K, Yoshida T, Koyanagi Y, Matsuda Z, Yamamoto N.

Cancer Sci. 2007 Mar;98(3):373-9.

25.

Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.

Chiba-Mizutani T, Miura H, Matsuda M, Matsuda Z, Yokomaku Y, Miyauchi K, Nishizawa M, Yamamoto N, Sugiura W.

J Clin Microbiol. 2007 Feb;45(2):477-87. Epub 2006 Dec 20.

26.

Rapid propagation of low-fitness drug-resistant mutants of human immunodeficiency virus type 1 by a streptococcal metabolite sparsomycin.

Miyauchi K, Komano J, Myint L, Futahashi Y, Urano E, Matsuda Z, Chiba T, Miura H, Sugiura W, Yamamoto N.

Antivir Chem Chemother. 2006;17(4):167-74.

PMID:
17066895
27.
28.

The interaction of HIV-1 with the host factors.

Komano J, Futahashi Y, Urano E, Miyauchi K, Murakami T, Matsuda Z, Yamamoto N.

Jpn J Infect Dis. 2005 Jun;58(3):125-30. Review.

29.

Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.

Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z.

J Virol. 2005 Apr;79(8):4720-9.

30.

Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses.

Komano J, Miyauchi K, Matsuda Z, Yamamoto N.

Mol Biol Cell. 2004 Dec;15(12):5197-207. Epub 2004 Sep 22.

31.

Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1.

Myint L, Matsuda M, Matsuda Z, Yokomaku Y, Chiba T, Okano A, Yamada K, Sugiura W.

Antimicrob Agents Chemother. 2004 Feb;48(2):444-52.

32.

Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.

J Virol. 2004 Feb;78(3):1324-32.

33.

Rapid phenotypic assay for human immunodeficiency virus type 1 protease using in vitro translation.

Iga M, Matsuda Z, Okayama A, Sugiura W, Hashida S, Morishita K, Nagai Y, Tsubouchi H.

J Virol Methods. 2002 Oct;106(1):25-37.

PMID:
12367727
34.

Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1.

Sugiura W, Matsuda Z, Yokomaku Y, Hertogs K, Larder B, Oishi T, Okano A, Shiino T, Tatsumi M, Matsuda M, Abumi H, Takata N, Shirahata S, Yamada K, Yoshikura H, Nagai Y.

Antimicrob Agents Chemother. 2002 Mar;46(3):708-15.

35.

Transcriptional regulation of HIV-1 LTR during antigen-dependent activation of primary T cells by dendritic cells.

Tsunetsugu-Yokota Y, Kato T, Yasuda S, Matsuda Z, Suzuki Y, Koyanagi Y, Yamamoto N, Akagawa K, Cho MW, Takemori T.

J Leukoc Biol. 2000 Mar;67(3):432-40.

PMID:
10733105
36.

Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.

Philippon V, Matsuda Z, Essex M.

J Hum Virol. 1999 May-Jun;2(3):167-74.

PMID:
10413368
37.

Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.

Sugiura W, Matsuda M, Matsuda Z, Abumi H, Okano A, Oishi T, Moriya K, Yamamoto Y, Fukutake K, Mimaya J, Ajisawa A, Taki M, Yamada K, Nagai Y.

J Hum Virol. 1999 May-Jun;2(3):146-53.

PMID:
10413366
38.

Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.

Yu XF, Matsuda Z, Yu QC, Lee TH, Essex M.

J Gen Virol. 1995 Dec;76 ( Pt 12):3171-9.

PMID:
8847526
39.

Gene therapy against retroviral diseases.

Essex M, Matsuda Z, Yu X, Lee TH.

Leukemia. 1995 Oct;9 Suppl 1:S71-4. Review.

PMID:
7475320
40.

Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses.

Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T, Miyata T, Kaba H, Higuchi T, Okutani F, et al.

FEBS Lett. 1995 Jul 24;368(3):455-60.

41.

An electron-lucent region within the virion distinguishes HIV-1 from HIV-2 and simian immunodeficiency virus.

Yu QC, Matsuda Z, Yu X, Ito S, Essex M, Lee TH.

AIDS Res Hum Retroviruses. 1994 Jun;10(6):757-61.

PMID:
8074937
42.
43.

A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1.

Matsuda Z, Yu X, Yu QC, Lee TH, Essex M.

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3544-8.

45.

Human immunodeficiency virus vpr gene encodes a virion-associated protein.

Yuan X, Matsuda Z, Matsuda M, Essex M, Lee TH.

AIDS Res Hum Retroviruses. 1990 Nov;6(11):1265-71.

PMID:
2150318
46.

The arcB gene of Escherichia coli encodes a sensor-regulator protein for anaerobic repression of the arc modulon.

Iuchi S, Matsuda Z, Fujiwara T, Lin EC.

Mol Microbiol. 1990 May;4(5):715-27.

PMID:
2201868
47.

Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome.

Matsuda Z, Chou MJ, Matsuda M, Huang JH, Chen YM, Redfield R, Mayer K, Essex M, Lee TH.

Proc Natl Acad Sci U S A. 1988 Sep;85(18):6968-72.

49.

[Clinical studies on M-proteinemia. 1. Statistical studies].

Aoki T, Matsuda Z, Yamada H, Kawai T.

Rinsho Byori. 1972 Aug;20(8):551-6. Japanese. No abstract available.

PMID:
4630042
50.

[Significance of serum inactivation on CRP test. 2. Factors involved on serum inactivation].

Kawai T, Matsuda Z, Yamada H, Domoto N, Okazaki H.

Rinsho Byori. 1971 Oct;19(10):685-8. Japanese. No abstract available.

PMID:
5169391

Supplemental Content

Loading ...
Support Center